Brief: Corline Biomedical Q3 pre-tax loss narrows to SEK 987,000
Nov 16 (Reuters) - CORLINE BIOMEDICAL AB CLBIO.ST :
* Q3 PRE-TAX LOSS SEK 987,000 VERSUS LOSS SEK 1.3 MILLION
YEAR AGO
Source text for Eikon: ID:nGNE1QgVFN
Further company coverage: CLBIO.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Corline Biomedical AB
See all newsBrief: Corline Biomedical Expectes Positive EBITDA In 2027
Brief: Corline Biomedical: Canada To Grant Kardium Up To C$31.25 Mln For Manufacturing Capacity Expansion
Brief: Corline Biomedical Q2 Net Sales Amount To SEK 4.7 Million
Brief: Corline Biomedical Partner Kardium Receives Approval For Globe Pulsed Field System In Canada
Brief: Corline Biomedical Q1 Result After Financial Items At SEK -2.5 Mln